APA (7th ed.) Citation

L, M., CI, O., CL, B., R, G., CV, O., D, S., . . . RT, U. (2025). ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. Nature communications, 16(1), 10983. https://doi.org/10.1038/s41467-025-66800-x

Chicago Style (17th ed.) Citation

L, Meder, et al. "ERBB2 Signaling Drives Immune Cell Evasion and Resistance Against Immunotherapy in Small Cell Lung Cancer." Nature Communications 16, no. 1 (2025): 10983. https://doi.org/10.1038/s41467-025-66800-x.

MLA (9th ed.) Citation

L, Meder, et al. "ERBB2 Signaling Drives Immune Cell Evasion and Resistance Against Immunotherapy in Small Cell Lung Cancer." Nature Communications, vol. 16, no. 1, 2025, p. 10983, https://doi.org/10.1038/s41467-025-66800-x.